In concordance with our observations at the proteome and transcriptome level, LGALS3BP positive staining was numerically increased in recurrent HCC tumor explants, compared to non-recurrent, when examining the 11 samples from our discovery cohort (Fig. 6A). The gene discussed is LGALS3BP; the disease is hepatocellular carcinoma.